SG Americas Securities’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$229K Sell
26,987
-66,675
-71% -$635K ﹤0.01% 2581
2025
Q4
$1.14M Buy
93,662
+38,166
+69% +$464K ﹤0.01% 1912
2025
Q3
$649K Buy
55,496
+45,061
+432% +$539K ﹤0.01% 1889
2025
Q2
$97K Sell
10,435
-21,055
-67% -$165K ﹤0.01% 2644
2025
Q1
$231K Sell
31,490
-40,208
-56% -$309K ﹤0.01% 2432
2024
Q4
$612K Buy
71,698
+26,511
+59% +$259K ﹤0.01% 1158
2024
Q3
$393K Buy
+45,187
New +$372K ﹤0.01% 1907
2024
Q2
Sell
-28,946
Closed -$263K 3179
2024
Q1
$263K Buy
28,946
+9,300
+47% +$66K ﹤0.01% 1774
2023
Q4
$88K Buy
19,646
+7,404
+60% +$21.9K ﹤0.01% 2806
2023
Q3
$38K Buy
+12,242
New +$50.1K ﹤0.01% 2984
2023
Q2
Sell
-33,849
Closed -$178K 2911
2023
Q1
$178K Buy
+33,849
New +$161K ﹤0.01% 2516
2022
Q4
Sell
-15,285
Closed -$63K 3286
2022
Q3
$63K Buy
15,285
+5,191
+51% +$26.1K ﹤0.01% 2956
2022
Q2
$41K Buy
+10,094
New +$38.1K ﹤0.01% 3290
2022
Q1
Sell
-18,415
Closed -$128K 3304
2021
Q4
$128K Sell
18,415
-20,686
-53% -$161K ﹤0.01% 2923
2021
Q3
$391K Buy
+39,101
New +$439K ﹤0.01% 2717
2021
Q2
Sell
-15,072
Closed -$247K 3120
2021
Q1
$247K Buy
15,072
+4,294
+40% +$82.7K ﹤0.01% 2527
2020
Q4
$223K Buy
+10,778
New +$160K ﹤0.01% 2568
2020
Q3
Sell
-28,347
Closed -$236K 3221
2020
Q2
$236K Buy
28,347
+12,779
+82% +$84.7K ﹤0.01% 2719
2020
Q1
$77K Buy
+15,568
New +$76.9K ﹤0.01% 3081
2019
Q4
Sell
-10,553
Closed -$32K 3392
2019
Q3
$32K Buy
+10,553
New +$47.2K ﹤0.01% 2865
2017
Q2
Sell
-49,024
Closed -$455K 3408
2017
Q1
$455K Buy
+49,024
New +$408K ﹤0.01% 1914
2015
Q2
Sell
-2,471
Closed -$104K 2756
2015
Q1
$104K Buy
+2,471
New +$81.2K ﹤0.01% 2260

Other funds holding OCUL